On-time osteoporosis remedies are important for reaping their complete prevention added benefits, according to a new study.
In a study of two,594 adults initiating denosumab for non-cancer indications (Prolia), on-time injections — defined as administering the subsequent injection inside four weeks just after the encouraged date — had a substantially reduced cumulative danger for all fractures compared with a delayed dosing schedule, Houchen Lyu, MD, PhD, of the General Hospital of Chinese PLA in Beijing, and colleagues reported in Annals of Internal Medicine.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.